Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Income from Continuing Operations (2022 - 2025)

Historic Income from Continuing Operations for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$6.2 million.

  • Envoy Medical's Income from Continuing Operations fell 1800.99% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.4 million, marking a year-over-year decrease of 249.28%. This contributed to the annual value of -$20.1 million for FY2024, which is 933.06% down from last year.
  • Per Envoy Medical's latest filing, its Income from Continuing Operations stood at -$6.2 million for Q3 2025, which was down 1800.99% from -$5.7 million recorded in Q2 2025.
  • Over the past 5 years, Envoy Medical's Income from Continuing Operations peaked at $12.5 million during Q1 2022, and registered a low of -$6.7 million during Q4 2023.
  • Over the past 4 years, Envoy Medical's median Income from Continuing Operations value was -$4.9 million (recorded in 2024), while the average stood at -$1.9 million.
  • The largest annual percentage gain for Envoy Medical's Income from Continuing Operations in the last 5 years was 2662.5% (2024), contrasted with its biggest fall of 78552.22% (2024).
  • Over the past 4 years, Envoy Medical's Income from Continuing Operations (Quarter) stood at -$2.0 million in 2022, then plummeted by 234.69% to -$6.7 million in 2023, then grew by 26.63% to -$4.9 million in 2024, then dropped by 25.26% to -$6.2 million in 2025.
  • Its Income from Continuing Operations was -$6.2 million in Q3 2025, compared to -$5.7 million in Q2 2025 and -$5.6 million in Q1 2025.